Nov 7 |
Ardent Health Partners GAAP EPS of $0.19, revenue of $1.45B
|
Nov 6 |
Ardent Health Reports Third Quarter 2024 Results
|
Nov 6 |
Hospital stocks could see negative impact under Trump
|
Nov 5 |
Ardent Health to Participate in Upcoming Investor Conferences
|
Oct 24 |
Ardent Health Announces Third Quarter 2024 Results Conference Call and Webcast Date
|
Oct 11 |
KeyBanc sees hospitals beating/raising with Q3 earnings
|
Sep 30 |
Ardent Health Added to Russell 2000® and 3000® Indexes
|
Sep 18 |
Ardent Health Completes Term Loan Repricing
|
Sep 3 |
Ardent Health Appoints Dave Styblo to Lead Investor Relations
|
Aug 28 |
Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
|